Bio-Path (BPTH) Short Interest Ratio & Short Volume → Biden replacement revealed? (From Paradigm Press) (Ad) Free BPTH Stock Alerts $2.49 -0.19 (-7.09%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Bio-Path Short Interest DataCurrent Short Volume67,400 sharesPrevious Short Volume63,400 sharesChange Vs. Previous Month+6.31%Dollar Volume Sold Short$277,688.00Short Interest Ratio / Days to Cover2.7Last Record DateMarch 31, 2024Outstanding Shares680,000 sharesFloat Size751,700 sharesShort Percent of Float8.97%Today's Trading Volume163,632 sharesAverage Trading Volume1,133,782 sharesToday's Volume Vs. Average14% Short Selling Bio-Path ? Sign up to receive the latest short interest report for Bio-Path and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBPTH Short Interest Over TimeBPTH Days to Cover Over TimeBPTH Percentage of Float Shorted Over Time Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Bio-Path Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202467,400 shares $277,688.00 +6.3%9.0%2.7 $4.12 3/15/202463,400 shares $291,640.00 +284.2%9.6%3 $4.60 2/29/202416,500 shares $100,320.00 -14.5%2.7%1.7 $6.08 2/15/202419,300 shares $170,612.00 -94.9%3.1%2.9 $8.84 1/31/2024378,300 shares $162,669.00 -6.0%N/A3.5 $0.43 1/15/2024402,500 shares $201,250.00 +7.3%N/A1.7 $0.50 Get the Latest News and Ratings for BPTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023375,200 shares $173,717.60 -12.9%N/A0.1 $0.46 12/15/2023430,900 shares $202,523.00 -18.6%N/A0.2 $0.47 11/30/2023529,600 shares $296,576.00 -23.9%N/A0.2 $0.56 11/15/2023695,700 shares $371,225.52 -28.3%N/A0.3 $0.53 10/31/2023969,600 shares $639,451.20 +240.3%N/A0.4 $0.66 10/15/2023284,900 shares $213,675.00 +66.9%N/A0.1 $0.75 9/30/2023170,700 shares $63,159.00 -21.2%N/A0.5 $0.37 9/15/2023216,700 shares $88,847.00 +23.1%N/A0.6 $0.41 8/31/2023176,000 shares $72,652.80 -19.4%N/A0.5 $0.41 8/15/2023218,300 shares $82,735.70 -46.7%N/A0.7 $0.38 7/31/2023409,300 shares $433,858.00 +44.1%N/A1.4 $1.06 7/15/2023284,000 shares $369,200.00 +44.8%N/A6.9 $1.30 6/30/2023196,200 shares $349,236.00 +111.9%N/A5.8 $1.78 6/15/202392,600 shares $152,780.74 +15.3%N/A2.8 $1.65 5/31/202380,300 shares $132,495.00 +7.5%N/A3 $1.65 5/15/202374,700 shares $112,050.00 +6.1%N/A2.5 $1.50 4/30/202370,400 shares $99,264.00 -15.8%N/A2.3 $1.41 4/15/202383,600 shares $116,195.64 +10.0%N/A2.4 $1.39 3/31/202376,000 shares $105,640.00 +18.6%N/A2.1 $1.39 3/15/202364,100 shares $96,150.00 -9.7%N/A1.7 $1.50 2/28/202371,000 shares $128,510.00 +59.2%N/A1.8 $1.81 2/15/202344,600 shares $88,018.10 +49.7%N/A1.1 $1.97 1/31/202329,800 shares $61,984.00 +122.4%N/A0.4 $2.08 1/15/202313,400 shares $23,986.00 -53.2%N/A0.2 $1.79 12/30/202228,600 shares $43,186.00 -21.6%N/A0.5 $1.51 12/15/202236,500 shares $54,385.00 +644.9%N/A0.6 $1.49 11/30/20224,900 shares $7,203.00 -84.9%N/A0.1 $1.47 11/15/202232,500 shares $49,725.00 -5.3%N/A0.6 $1.53 10/31/202234,300 shares $111,475.00 +0.3%2.0%0.8 $3.25 10/15/202234,200 shares $110,466.00 -0.9%2.0%2 $3.23 9/30/202234,500 shares $110,055.00 -7.0%2.0%1.7 $3.19 9/15/202237,100 shares $139,867.00 -13.3%2.2%1.3 $3.77 8/31/202242,800 shares $156,648.00 -11.0%2.5%1.4 $3.66 8/15/202248,100 shares $198,653.00 -7.5%2.8%1.4 $4.13Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here BPTH Short Interest - Frequently Asked Questions What is Bio-Path's current short interest? Short interest is the volume of Bio-Path shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 67,400 shares of BPTH short. 8.97% of Bio-Path's shares are currently sold short. Learn More on Bio-Path's current short interest. What is a good short interest ratio for Bio-Path? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPTH shares currently have a short interest ratio of 3.0. Learn More on Bio-Path's short interest ratio. What is a good short interest percentage for Bio-Path? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.97% of Bio-Path's floating shares are currently sold short. Is Bio-Path's short interest increasing or decreasing? Bio-Path saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 67,400 shares, an increase of 6.3% from the previous total of 63,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bio-Path's float size? Bio-Path currently has issued a total of 680,000 shares. Some of Bio-Path's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Path currently has a public float of 751,700 shares. How does Bio-Path's short interest compare to its competitors? 8.97% of Bio-Path's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bio-Path: Galmed Pharmaceuticals Ltd. (1.10%), PainReform Ltd. (1.21%), Lucy Scientific Discovery Inc. (2.95%), Qualigen Therapeutics, Inc. (1.74%), InMed Pharmaceuticals Inc. (0.17%), Clearmind Medicine Inc. (6.12%), 180 Life Sciences Corp. (8.36%), NeuBase Therapeutics, Inc. (4.92%), Salarius Pharmaceuticals, Inc. (6.72%), Notable Labs, Ltd. (0.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Bio-Path stock? Short selling BPTH is an investing strategy that aims to generate trading profit from Bio-Path as its price is falling. BPTH shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bio-Path? A short squeeze for Bio-Path occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPTH, which in turn drives the price of the stock up even further. How often is Bio-Path's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPTH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GLMD Short Squeeze PRFX Short Squeeze LSDI Short Squeeze QLGN Short Squeeze INM Short Squeeze CMND Short Squeeze ATNF Short Squeeze NBSE Short Squeeze SLRX Short Squeeze NTBL Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BPTH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry